Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome. Diabetes 2013;62:1084–1093

In the article listed above, there are errors in Figures 3, 4, and 5, which show the effects of quercetin and apigenin in …

| Table of Contents
OPEN ACCESS ARTICLE

This Article

  1. doi: 10.2337/db14-er04 Diabetes vol. 63 no. 4 1428
  1. Free via Open Access: OA